Overview
Markus Fleisch practices in Wuppertal, Germany. Mr. Fleisch is rated as an Experienced expert by MediFind in the treatment of 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency. His top areas of expertise are Triple-Negative Breast Cancer, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Endometrial Cancer, and Bannayan-Riley-Ruvalcaba Syndrome.
His clinical research consists of co-authoring 42 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Triple-Negative Breast CancerMr. Fleisch isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
- Bannayan-Riley-Ruvalcaba SyndromeMr. Fleisch isExperienced. Learn about Bannayan-Riley-Ruvalcaba Syndrome.
- Breast CancerMr. Fleisch isExperienced. Learn about Breast Cancer.
- ChoriocarcinomaMr. Fleisch isExperienced. Learn about Choriocarcinoma.
- Compartment SyndromeMr. Fleisch isExperienced. Learn about Compartment Syndrome.
- Cowden SyndromeMr. Fleisch isExperienced. Learn about Cowden Syndrome.